Access disease-level, longitudinal, oncology patient data to inform life science research, development, and commercial strategies with Vantage.
From R&D to post marketing and HEOR, Vantage helps oncology biopharma teams identify opportunities and create enterprise level strategies for specific cancer diagnoses.
Conduct Phase IV and HEOR studies and optimize commercial strategy.
COTA’s database of patients includes longitudinal treatment and outcomes data for oncology patients including:
Explore our collection of clinical research, recent press, podcasts, and more.
Each year, ISPOR brings together members of the health economics and outcomes research (HEOR) community for a celebration of the...
As we recognize Women’s Health Month and approach Mother’s Day, this is a chance to lead differently. We can ask...
How real-world data can tell the story of breast, ovarian and uterine cancers at a pivotal moment in women’s health...
Discover the power of real-world cancer data for your life science organization.
